1. ADMA Biologics Announces Martha J. Demski Elected to Board of Directors

    ADMA Biologics Announces Martha J. Demski Elected to Board of Directors

    ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced that the proposed resolution to elect Martha J. Demski to its Board of Directors was approved at the Company’s recent Annual Shareholder Meeting, held June 18, 2020...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content
  2. Quotes

    1. Martha has a long track record of success serving in executive leadership roles in both finance and manufacturing, as well as on the Boards of several leading biotechnology companies.
    2. With the commercializations of BIVIGAM and ASCENIV, as well as the expansion of its plasma collection facilities, ADMA is an exciting story in biotechnology and is well-positioned for substantial growth.
  3. Topics Mentioned